AMISOLAN 200 amisulpride 200 mg uncoated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

amisolan 200 amisulpride 200 mg uncoated tablet blister pack

southern cross pharma pty ltd - amisulpride -

PHARMACOR AMISULPRIDE amisulpride 100 mg uncoated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

pharmacor amisulpride amisulpride 100 mg uncoated tablet blister pack

southern cross pharma pty ltd - amisulpride -

PHARMACOR AMISULPRIDE amisulpride 400 mg uncoated tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

pharmacor amisulpride amisulpride 400 mg uncoated tablet blister pack

southern cross pharma pty ltd - amisulpride -

Amisulpride 200 mg Tablets Irlanda - engleză - HPRA (Health Products Regulatory Authority)

amisulpride 200 mg tablets

mcdermott laboratories ltd., t/a gerard laboratories - amisulpride - tablet - 200 milligram(s) - benzamides; amisulpride

Sulprix Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

sulprix

viatris limited - amisulpride 200mg;   - tablet - 200 mg - active: amisulpride 200mg   excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

SULPRIX amisulpride 200 mg tablets blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

sulprix amisulpride 200 mg tablets blister pack

alphapharm pty ltd - amisulpride, quantity: 200 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; lactose monohydrate; sodium starch glycollate type a - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Amisulpride 200 Winthrop Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

amisulpride 200 winthrop

sanofi-aventis new zealand limited - amisulpride 200mg;  ;   - tablet - 200 mg - active: amisulpride 200mg     excipient: hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose sodium starch glycolate

SOLIAN 200 amisulpride 200 mg tablet blister pack Australia - engleză - Department of Health (Therapeutic Goods Administration)

solian 200 amisulpride 200 mg tablet blister pack

sanofi-aventis australia pty ltd - amisulpride, quantity: 200 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; hypromellose; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Amisulprid Sandoz 200 mg tabl. Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amisulprid sandoz 200 mg tabl.

sandoz sa-nv - amisulpride 200 mg - tablet - 200 mg - amisulpride 200 mg - amisulpride

Solian 200 mg tabl. Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

solian 200 mg tabl.

sanofi belgium sa-nv - amisulpride 200 mg - tablet - 200 mg - amisulpride 200 mg - amisulpride